Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial

BACKGROUND: A standard low-dosing schedule of rituximab (RTX; 2 × 500 mg or 1 × 1000 mg) is as effective for active rheumatoid arthritis (RA) as the registered dose (2 × 1000 mg). Moreover, several small uncontrolled studies suggest that even lower-dosed treatment with RTX also leads to good treatme...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Trials
Autors principals: den Broeder, Alfons A., Verhoef, Lise M., Fransen, Jaap, Thurlings, Rogier, van den Bemt, Bart J. F., Teerenstra, Steven, Boers, Nadine, den Broeder, Nathan, van den Hoogen, Frank H. J.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5577818/
https://ncbi.nlm.nih.gov/pubmed/28854956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-017-2134-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars